Tradestie Institutional Equity Comparison Engine

ABPWW vs SGMO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-05-04 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SGMO Overall Edge

SGMO Captures Institutional Edge (4โ€“0 Pillars ยท 10โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sangamo Therapeutics, Inc. Common Stock (SGMO) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ABPWW trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus SGMO at 0.4x Forward P/E and -175.5% operating margin (+88.4% YoY). In options structure, ABPWW sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SGMO sits in UNCLASSIFIED (71st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner SGMO
ABPWW N/M vs SGMO 0.4x Fwd P/E
Growth & Margin Winner SGMO
Op Margin N/A vs -175.5% ยท YoY N/A vs +88.4%
Momentum & Technical Winner SGMO
1Y -80.8% vs -76.0% ยท 52W Pos 0% vs 9%
Options & Structure Winner SGMO
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (71st %ile IV)
ABPWW NASDAQ
Abpro Holdings, Inc. Warrant
Institutional Equity
$0.01
+0.0% 1D
Market Cap N/A
1M Return -17.86%
1Y Return -80.83%
Forward P/E N/M
Unified AI Score
45.0 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
SGMO NASDAQ
Sangamo Therapeutics, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.18
+31.56% 1D
Market Cap $55.9M
1M Return -40.82%
1Y Return -76.04%
Forward P/E 0.4x
Unified AI Score
52.0 / 100 HOLD
Tech 25.0 Fund 46.0 Flow 65.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABPWW -80.83% SGMO -76.04% Spread: +8.96 pp (ABPWW Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ABPWW TTM Op. Margin: N/A SGMO TTM Op. Margin: -175.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABPWW vs SGMO. Trailing 12-month operating profitability (ABPWW N/A vs SGMO -175.5%) and valuation multiples (ABPWW N/M vs SGMO 0.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABPWW (0) vs SGMO (10)
Institutional Metric ABPWW SGMO Criterion Row Winner
Market Capitalization Scale N/A $55.9M Larger Scale SGMO
Trailing P/E Ratio Valuation N/M 0.4x Lower Multiple SGMO
Forward P/E Ratio Valuation N/M 0.4x Lower Multiple SGMO
Revenue Growth (YoY) Growth N/A +88.4% Higher Growth SGMO
Operating Margin (TTM) Profitability N/A -175.5% Higher Margin SGMO
Net Profit Margin Profitability N/A 0.0% Higher Margin SGMO
Return on Equity (ROE) Capital Efficiency N/A -2891.8% Higher ROE SGMO
52-Week Range Position Momentum 0% ($0โ€“$0) 9% ($0โ€“$1) Stronger Trend SGMO
Beta / 30D Volatility Risk Regime -1.56ฮฒ ยท 265% Vol 1.49ฮฒ ยท 206% Vol Lower Realized Risk SGMO
Unified Institutional Score Composite Signal 45.0 / 100 (HOLD) 52.0 / 100 (HOLD) Higher Composite SGMO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABPWW vs SGMO Buy Guide
ABPWW UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ABPWW Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SGMO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 71st %ile
IV Regime Elevated (60thโ€“80th %ile)
Live SGMO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABPWW nor SGMO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.